ÜSÜmran Sofu

Ümran Sofu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ümran Sofu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development of a Sustainable and Low-Cost Voltammetric Method for the Determination of Doxycycline in Milk Samples

    by Ümran Sofu, Mohammed Gamalaldin Khalafalla Mohammed, Ebru Çubuk Demiralay, Gökçe Öztürk, Rukiye Taşdemir, Kerim Yapıcı

  • Open Access

    Effects of washing, oxidation, carboxylation, and hydrophobicity on the antibacterial activity of graphene oxide and reduced graphene oxide

    by Emi̇r Boztepe, Ceren Poyraz, Ruki̇yE Taşdemi̇r, Ebru Önem, Ümran Sofu, Keri̇m Yapici

    In this study, the effects of number of washes, oxidation degree, carboxylation, and hydrothermal reduction temperature on the antibacterial activity of graphene oxide (GO) and reduced graphene oxide (rGO) nanomaterials were investigated. GO derivatives with different numbers of washes (1–5W) and oxidation levels (3X, 6X, and 9X), carboxylated GO (GO-COOH), and rGO samples obtained at different hydrothermal reduction temperatures (100, 140, and 180 °C) were characterized by X-ray diffraction, field-emission scanning electron microscopy, Fourier-transform infrared spectroscopy, zeta potential analysis, and Raman spectroscopy, and were subsequently evaluated for antibacterial activity against gram-positive Staphylococcus aureus (S. aureus) and gram-negative Escherichia coli (E. coli). The washing experiments showed that, in the presence of residual acids (1W), a 5-log reduction was achieved for S. aureus at 600 μg/mL, whereas after acid removal (5W), purified GO produced a 2-log reduction at the same concentration. In contrast, no meaningful change in activity was observed for E. coli as a function of number of washes (~1 log). In the oxidation optimization experiments, the 6X oxidation level yielded the highest antibacterial efficacy against S. aureus, producing a 5-log reduction at 800 μg/mL, while excessive oxidation (9X) led to a plateau in activity because of structural defects. Carboxylation decreased activity against S. aureus by 40% at 800 μg/mL (from 5 log to 3 log) because of electrostatic repulsion, while leaving the already low activity against E. coli (~1 log) unchanged. In the hydrothermal reduction experiments, partial reduction at 100 °C produced the optimal hydrophilic–hydrophobic balance for S. aureus (3-log reduction at 240 μg/mL), whereas the higher hydrophobicity at 180 °C enabled effective inhibition of E. coli (2- to 3-log reduction at 180–240 μg/mL). These findings show that antibacterial efficacy depends on the compatibility between surface chemical properties and bacterial cell-wall structure.

  • Electrochemical investigation of buclizine: First mechanistic study of proton-coupled electron transfer at a glassy carbon electrode

    by Ümran Sofu, Gökçe Öztürk, Zehra Üstün, Ebru Çubuk Demiralay

    This study reports, for the first time, the electrochemical oxidation behavior of buclizine at a glassy carbon electrode using cyclic and differential pulse voltammetry. The effects of solvent composition, methanol content, pH, supporting electrolyte, and scan rate on the oxidation process were systematically examined. Optimal electrochemical signals were obtained in Britton-Robinson buffer at pH 4.0 containing 10% (v/v) methanol. The oxidation peak potential shifted toward more negative values with increasing pH, with slopes close to 59 mV/pH in both voltammetric techniques, indicating that the oxidation involves equal numbers of electrons and protons. Scan rate studies combined with Laviron analysis confirmed that the oxidation proceeds via a single-electron transfer. Based on the experimental findings, an irreversible proton-coupled electron transfer mechanism involving one electron and one proton (1 e⁻ / 1 H⁺) was proposed. The findings in this article provide the first experimental information on the electrochemical oxidation pathway of buclizine, offering important data for understanding the chemical stability and pharmaceutical quality of the compound.